Longevity InTime Email Format

Biotechnology ResearchDelaware, United States11-50 Employees

Longevity InTime BioTech develops an AI-driven platform that simulates clinical trials to de-risk human studies and accelerate regulatory decisions. The system runs hundreds of blinded trial scenarios to help longevity-focused biotechs optimize trial design, estimate success probabilities, and reduce regulatory risk. By applying causal AI, the company aims to enable faster and cheaper development of aging therapies, targeting the first generation of approved treatments in this area. All methods are proprietary and patent-pending, with priority claims in the field, and the firm pursues related work in disease prediction and organizing medical data. 

Headquartered in Wilmington, Delaware, the company operates with a small-to-mid-sized team within the biotechnology research sector. Its approach centers on AI-assisted trial design for aging-related therapies, underpinned by patent-pending methodologies intended to accelerate the path to approval.

Get verified Longevity InTime emails free

Company overview Employee directory